To overcome the barriers and to improve the adherence, oral GLP-1 RAs were needed, but oral protein-based drug absorption is limited because of degradation in the stomach due to low pH, proteolytic enzyme activity, and limited permeability across the gastrointestinal (GI) epithelium
Retrieved from Eli Lilly-c
Key takeaways Ozempic overdose is possible and can lead to severe nausea, vomiting, abdominal pain, and, in rare cases, pancreatitis or intestinal blockage
Evidence from approved GLP-1 receptor agonists provides relevant context, though it is important to note that some interactions are agent-specific rather than class-wide effects
Patients with a history of pancreatitis, gallstones, or hypertriglyceridemia face elevated baseline risk